Adobe Inc.
—- Market cap
- —
- Debt
- +$6.21B
- Cash
- −$5.43B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ADBE stock price vs UNH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at UNH's multiple
Needs UNH P/E.
Implied fair value · at ADBE's multiple
Needs ADBE P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ADOBE INC. · implied price per share
Bear
$260.76
Base
$306.53
Bull
$366.14
UnitedHealth Group Incorporated · implied price per share
Bear
$222.49
Base
$271.41
Bull
$335.10
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
ADBE vs MSFT
Salesforce, Inc.
ADBE vs CRM
ORACLE CORP
ADBE vs ORCL
INTERNATIONAL BUSINESS MACHINES CORP
ADBE vs IBM
TYLER TECHNOLOGIES INC
ADBE vs TYL
Autodesk, Inc.
ADBE vs ADSK
HUMANA INC
ADBE vs HUM
CENTENE CORP
ADBE vs CNC
CVS Health Corporation
ADBE vs CVS
Elevance Health, Inc.
ADBE vs ELV
MOLINA HEALTHCARE, INC.
ADBE vs MOH
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ADBE's superior margins and balance-sheet quality will continue to justify a premium sales multiple, then favor ADBE because its 36.6% operating margin, 30.0% net margin, and 7/9 F-Score support a stronger relative-quality case than UNH.
ADBE trades at 15.9x P/E versus UNH at 30.8x, yet the model implies a price of $513.85 for ADBE, or 93.8% upside from $265.21. The gap is driven more by the specific relative-valuation framework and ADBE's superior quality metrics than by UNH-comparable operating scale.
Supporting Metrics